Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j

European Journal of Immunology

Volumn 36, Issue 3, 2006, Pages 732-741

  Cerboni, Cristina ^a,b   Achour, Adnane ^c   Wärnmark, Anette ^d   Mousavi Jazi, Mehrdad ^e   Sandalova, Tatyana ^d   Hsu, Mei Ling ^f   Cosman, David ^f   Kärre, Klas ^a,d   Carbone, Ennio ^a,g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f AMGEN INC   (United States)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Human CMV; Leukocyte Ig like receptor 1; NK cells; UL18

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA G1 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE LIKE IMMUNOGLOBULIN RECEPTOR 1; NATURAL KILLER CELL RECEPTOR; PROTEIN UL18; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CELL ASSAY; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE CLUSTER; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MOLECULAR MODEL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SEQUENCE HOMOLOGY; SPONTANEOUS MUTATION; STRAIN DIFFERENCE; TARGET CELL; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

EID: 33644964890     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425220     Document Type: Article

References (43)

1. Alcami, A. and Koszinowski, U. H., Viral mechanisms of immune evasion. Immunol. Today 2000. 21: 447-455.
2. Ljünggren, H. G. and Kärre, K., In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990. 11: 237-244.
3. Cerboni, C., Mousavi-Jazi, M., Linde, A., Söderström, K., Brytting, M., Wahren, B., Kärre, K. and Carbone, E., Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J. Immunol. 2000. 164: 4775-4782.
4. Fletcher, J. M., Prentice, H. G. and Grundy, J. E., Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA. J. Immunol. 1998. 161: 2365-2374.
5. Polic, B., Jonjic, S., Pavic, I., Crnkovic, I., Zorica, I., Hengel, H., Lucin, P. and Koszinowski, U. H., Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo. J. Gen. Virol. 1996. 77: 217-225.
6. Tay, C. H., Welsh, R. M. and Brutkiewicz, R. R., NK cell response to viral infections in beta 2-microglobulin-deficient mice. J. Immunol. 1995. 154: 780-789.
7. Beck, S. and Barrell, B. G., Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988. 331: 269-272.
8. Farrell, H. E., Vally, H., Lynch, D. M., Fleming, P., Shellam, G. R., Scalzo, A. A. and Davis-Poynter, N. J., Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997. 386: 510-514.
9. Cretney, E., Degli-Esposti, M. A., Densley, E. H., Farrell, H. E., Davis-Poynter, N. J. and Smyth, M. J., m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 1999. 190: 435-444.
10. Kubota, A., Kubota, S., Farrell, H. E., Davis-Poynter, N. and Takei, F., Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell. Immunol. 1999. 191: 145-151.
11. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M. L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997. 7: 273-282.
12. Leong, C. C., Chapman, T. L., Bjorkman, P. J., Formankova, D., Mocarski, E. S., Phillips, J. H. and Lanier, L. L., Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 1998. 187: 1681-1687.
13. Reyburn, H. T., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Pazmany, L. and Strominger, J. L., The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 1997. 386: 514-517.
14. + T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 2004. 172: 5629-5637.
15. Vitale, M., Castriconi, R., Parolini, S., Pende, D., Hsu, M. L., Moretta, L., Cosman, D. and Moretta, A., The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: Analysis of LIR-1 + NK cell clones. Int. Immunol. 1999. 11: 29-35.
16. Browne, H., Smith, G., Beck, S. and Minson, T., A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 1990. 347: 770-772.
17. Fahnestock, M. L., Johnson, J. L., Feldman, R. M., Neveu, J. M., Lane, W. S. and Bjorkman, P. J., The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 1995. 3: 583-590.
18. Banham, A. H., Colonna, M., Cella, M., Micklem, K. J., Pulford, K., Willis, A. C. and Mason, D. Y., Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily. J. Leukoc. Biol. 1999. 65: 841-845.
19. Bellón, T., Kitzig, F., Sayos, J. and López-Botet, M., Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J. Immunol. 2002. 168: 3351-3359.
20. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R. and Borges, L., The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 1998. 28: 3423-3434.
21. Colonna, M., Navarro, F., Bellón, T., Llano, M., Garcia, P., Samaridis, J., Angman, L. et al., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
22. Lepin, E. J., Bastin, J. M., Allan, D. S., Roncador, G., Braud, V. M., Mason, D. Y., van der Merwe, P. A. et al., Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol. 2000. 30: 3552-3561.
23. Navarro, F., Llano, M., Bellón, T., Colonna, M., Geraghty, D. E. and López-Botet, M., The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 1999. 29: 277-283.
24. Chapman, T. L., Heikeman, A. P. and Bjorkman, P. J., The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999. 11: 603-613.
25. Willcox, B. E., Thomas, L. M. and Bjorkman, P. J., Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 2003. 4: 913-919.
26. Chapman, T. L., Heikema, A. P., West, A. P., Jr. and Bjorkman, P. J., Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 2000. 13: 727-736.
27. Prichard, M. N., Penfold, M. E., Duke, G. M., Spaete, R. R. and Kemble, G. W., A review of genetic differences between limited and extensively passaged human cytomegalovirus strains. Rev. Med. Virol. 2001. 11: 191-200.
28. Saverino, D., Fabbi, M., Ghiotto, F., Merlo, A., Bruno, S., Zarcone, D., Tenca, C. et al., The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 2000. 165: 3742-3755.
29. Cerboni, C., Mousavi-Jazi, M., Wakiguchi, H., Carbone, E., Kärre, K. and Söderström, K., Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. Eur. J. Immunol. 2001. 31: 2926-2935.
30. Kelley, L. A., MacCallum, R. M. and Sternberg, M. J., Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 2000. 299: 499-520.
31. Chapman, T. L. and Bjorkman, P. J., Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: Comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 1998. 72: 460-466.
32. Valés-Gómez, M., Shiroishi, M., Maenaka, K. and Reyburn, H. T., Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J. Virol. 2005. 79: 2251-2260.
33. Rouas-Freiss, N., Goncalves, R. M., Menier, C., Dausset, J. and Carosella, E. D., Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 1997. 94: 11520-11525.
34. Biassoni, R., Bottino, C., Millo, R., Moretta, L. and Moretta, A., Natural killer cell-mediated recognition of human trophoblast. Semin. Cancer Biol. 1999. 9: 13-18.
35. Fisher, S., Genbacev, O., Maidji, E. and Pereira, L., Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: Implications for transmission and pathogenesis. J. Virol. 2000. 74: 6808-6820.
36. Jun, Y., Kim, E., Jin, M., Sung, H. C., Han, H., Geraghty, D. E. and Ahn, K., Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J. Immunol. 2000. 164: 805-811.
37. Berg, L., Riise, G. C., Cosman, D., Bergstrom, T., Olofsson, S., Kärre, K., Carbone, E., LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet 2003. 361: 1099-1101.
38. French, A. R., Pingel, J. T., Wagner, M., Bubic, I., Yang, L., Kim, S., Koszinowski, U. et al., Escape of mutant double-stranded DNA virus from innate immune control. Immunity 2004. 20: 747-756.
39. Baum, P. R., Gayle, R. B., 3rd, Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F. et al., Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 1994. 13: 3992-4001.
40. Robertson, M. J., Cochran, K. J., Cameron, C., Le, J. M., Tantravahi, R. and Ritz, J., Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 1996. 24: 406-415.
41. Gianfrani, C., Oseroff, C., Sidney, J., Chesnut, R. W. and Sette, A., Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 2000. 61: 438-452.
42. Guex, N. and Peitsch, M. C., SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 1997. 18: 2714-2723.
43. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S. et al., Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 1998. 54: 905-921.